Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 3/2008

01-03-2008 | Original article

Radiation exposure to surgical staff during F-18-FDG-guided cancer surgery

Authors: P. A. Andersen, A. H. Chakera, T. L. Klausen, T. Binderup, H. S. Grossjohann, E. Friis, C. Palnaes Hansen, G. Schmidt, A. Kjaer, B. Hesse

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 3/2008

Login to get access

Abstract

Purpose

High-energy gamma probes have recently become commercially available, developed for 18F-FDG probe-guided surgery. The radiation received by the staff in the operating room might limit the use of it, but has never been determined. We therefore wanted to measure the absorbed staff doses at operations where patients had received a preoperative injection of 18F-FDG.

Methods

Thrity-four patients with different cancers (breast cancer, melanoma, gastrointestinal cancers, respectively) were operated. At every operation the surgeon was monitored with a TLD tablet on his finger of the operating hand and a TLD tablet on the abdomen. The surgeon and anaesthesiologist were also monitored using electronic dosimeters placed in the trousers lining at 25 operations.

Results

The dose rate to the surgeon’s abdominal wall varied between 7.5–13.2 μSv/h, depending on tumour location. The doses to the anaesthesiologists and the finger doses to the surgeon were much lower. About 350–400 MBq, i.e. ca. eight times higher activities than those used in the present study are supposed to be necessary for guiding surgery. It can be calculated from the body doses measured that a surgeon can perform between 150–260 h of surgery without exceeding permissible limits for professional workers.

Conclusions

The radiation load to the operating staff will generally be so small that it does not present any limitation for FDG-guided surgery. However, it is recommended to monitor the surgical staff considering that the surgeon may be exposed to other radiation sources, and since the staff often includes women of child-bearing age.
Literature
1.
go back to reference Jansen L, Nieweg OE, Peterse JL, Hoefnagel CA, Olmos RA, Kroon BB. Reliability of sentinel lymph node biopsy for staging melanoma. Br J Surg 2000;87:484–9.PubMedCrossRef Jansen L, Nieweg OE, Peterse JL, Hoefnagel CA, Olmos RA, Kroon BB. Reliability of sentinel lymph node biopsy for staging melanoma. Br J Surg 2000;87:484–9.PubMedCrossRef
2.
go back to reference McMasters KM, Tuttle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000;18:2560–6.PubMed McMasters KM, Tuttle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000;18:2560–6.PubMed
3.
go back to reference Veronesi U, Paganelli G, Viale G, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 1999;91:368–73.PubMedCrossRef Veronesi U, Paganelli G, Viale G, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 1999;91:368–73.PubMedCrossRef
4.
go back to reference Burak WE, Hollenbeck ST, Zervos EE, Hock KL, Kemp LC, Young DC. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 2002;183:23–7.PubMedCrossRef Burak WE, Hollenbeck ST, Zervos EE, Hock KL, Kemp LC, Young DC. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 2002;183:23–7.PubMedCrossRef
5.
go back to reference Wrightson WR, Wong SL, Edwards MJ, et al. Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg Oncol 2003;10:676–80.PubMedCrossRef Wrightson WR, Wong SL, Edwards MJ, et al. Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg Oncol 2003;10:676–80.PubMedCrossRef
6.
go back to reference Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006;355:1307–17.PubMedCrossRef Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 2006;355:1307–17.PubMedCrossRef
7.
go back to reference Werner JA, Dunne AA, Ramaswamy A, et al. The sentinel node concept in head and neck cancer: solution for the controversies in the N0 neck? Head Neck 2004;26:603–11.PubMedCrossRef Werner JA, Dunne AA, Ramaswamy A, et al. The sentinel node concept in head and neck cancer: solution for the controversies in the N0 neck? Head Neck 2004;26:603–11.PubMedCrossRef
8.
go back to reference Kroon BK, Horenblas S, Meinhardt W, et al. Dynamic sentinel node biopsy in penile carcinoma: evaluation of 10 years experience. Eur Urol 2005;47:601–6.PubMedCrossRef Kroon BK, Horenblas S, Meinhardt W, et al. Dynamic sentinel node biopsy in penile carcinoma: evaluation of 10 years experience. Eur Urol 2005;47:601–6.PubMedCrossRef
9.
go back to reference De CC, Sideri M, Bartolomei M, et al. Sentinel node biopsy in early vulvar cancer. Br J Cancer 2000;82:295–9.CrossRef De CC, Sideri M, Bartolomei M, et al. Sentinel node biopsy in early vulvar cancer. Br J Cancer 2000;82:295–9.CrossRef
10.
go back to reference Essner R, Hsueh EC, Haigh PI, Glass EC, Huynh Y, Daghighian F. Application of an [(18)F]fluorodeoxyglucose-sensitive probe for the intraoperative detection of malignancy. J Surg Res 2001;96:120–6.PubMedCrossRef Essner R, Hsueh EC, Haigh PI, Glass EC, Huynh Y, Daghighian F. Application of an [(18)F]fluorodeoxyglucose-sensitive probe for the intraoperative detection of malignancy. J Surg Res 2001;96:120–6.PubMedCrossRef
11.
go back to reference Yamamoto S, Matsumoto K, Sakamoto S, Tarutani K, Minato K, Senda M. An intra-operative positron probe with background rejection capability for FDG-guided surgery. Ann Nucl Med 2005;19:23–28.PubMedCrossRef Yamamoto S, Matsumoto K, Sakamoto S, Tarutani K, Minato K, Senda M. An intra-operative positron probe with background rejection capability for FDG-guided surgery. Ann Nucl Med 2005;19:23–28.PubMedCrossRef
12.
go back to reference Klausen TL, Chakera AH, Friis E, Rank F, Hesse B, Holm S. Radiation doses to staff involved in sentinel node operations for breast cancer. Clin Physiol Funct Imaging 2005;25:196–202.PubMedCrossRef Klausen TL, Chakera AH, Friis E, Rank F, Hesse B, Holm S. Radiation doses to staff involved in sentinel node operations for breast cancer. Clin Physiol Funct Imaging 2005;25:196–202.PubMedCrossRef
13.
go back to reference Waddington WA, Keshtgar MR, Taylor I, Lakhani SR, Short MD, Ell PJ. Radiation safety of the sentinel lymph node technique in breast cancer. Eur J Nucl Med 2000;27:377–91.PubMedCrossRef Waddington WA, Keshtgar MR, Taylor I, Lakhani SR, Short MD, Ell PJ. Radiation safety of the sentinel lymph node technique in breast cancer. Eur J Nucl Med 2000;27:377–91.PubMedCrossRef
14.
go back to reference Heckathorn E, Dimock C, Dhalbom M, Daghighian F. Radiation dose to surgical staff from F-18-FDG tumor localization and radiosurgery. In: Society of Nuclear Medicine 2005. Heckathorn E, Dimock C, Dhalbom M, Daghighian F. Radiation dose to surgical staff from F-18-FDG tumor localization and radiosurgery. In: Society of Nuclear Medicine 2005.
15.
go back to reference Radiation dose to patients from radiopharmaceuticals (addendum 2 to ICRP publication 53). Ann ICRP 1998;28:1–126. Radiation dose to patients from radiopharmaceuticals (addendum 2 to ICRP publication 53). Ann ICRP 1998;28:1–126.
16.
go back to reference ICRP publication 53. Radiation dose to patients from radiopharmaceuticals. Annals of the ICRP 1987;18. ICRP publication 53. Radiation dose to patients from radiopharmaceuticals. Annals of the ICRP 1987;18.
17.
go back to reference ICRP publication 66. Human Respiratory Tract Model for Radiological Protection. Annals of the ICRP 1994. ICRP publication 66. Human Respiratory Tract Model for Radiological Protection. Annals of the ICRP 1994.
18.
go back to reference ICRP publication 80. Radiation dose to patients from radiopharmaceuticals, addendum 2 to ICRP 53. Annals of the ICRP 1998;28. ICRP publication 80. Radiation dose to patients from radiopharmaceuticals, addendum 2 to ICRP 53. Annals of the ICRP 1998;28.
19.
go back to reference Gulec SA, Daghighian F and Essner R. PET-Probe: Evaluation of technical performance and clinical utility of a handheld high-energy gamma probe in oncologic surgery. Ann Surg Oncol 2006. Gulec SA, Daghighian F and Essner R. PET-Probe: Evaluation of technical performance and clinical utility of a handheld high-energy gamma probe in oncologic surgery. Ann Surg Oncol 2006.
20.
go back to reference Memorandum from the British Committee on Radiation Units and Measurements. Advice following ICRP publication 60. Br J Radiol 1993;66:1201–1203. Memorandum from the British Committee on Radiation Units and Measurements. Advice following ICRP publication 60. Br J Radiol 1993;66:1201–1203.
21.
go back to reference Franc BL, Mari C, Johnson D, Leong SP. The role of a positron-and high-energy gamma photon probe in intraoperative localization of recurrent melanoma. Clin Nucl Med 2005;30:787–91.PubMedCrossRef Franc BL, Mari C, Johnson D, Leong SP. The role of a positron-and high-energy gamma photon probe in intraoperative localization of recurrent melanoma. Clin Nucl Med 2005;30:787–91.PubMedCrossRef
22.
go back to reference Unscear 2000 report vol.II. Sources and effects of ionizing radiation. In: 2000. Unscear 2000 report vol.II. Sources and effects of ionizing radiation. In: 2000.
23.
go back to reference Bares R, Muller B, Fass J, Buell U, Schumpelick V. The radiation dose to surgical personnel during intraoperative radioimmunoscintimetry. Eur J Nucl Med 1992;19:110–12.PubMedCrossRef Bares R, Muller B, Fass J, Buell U, Schumpelick V. The radiation dose to surgical personnel during intraoperative radioimmunoscintimetry. Eur J Nucl Med 1992;19:110–12.PubMedCrossRef
24.
go back to reference Morton R, Horton PW, Peet DJ, Kissin MW. Quantitative assessment of the radiation hazards and risks in sentinel node procedures. Br J Radiol 2003;76:117–122.PubMedCrossRef Morton R, Horton PW, Peet DJ, Kissin MW. Quantitative assessment of the radiation hazards and risks in sentinel node procedures. Br J Radiol 2003;76:117–122.PubMedCrossRef
Metadata
Title
Radiation exposure to surgical staff during F-18-FDG-guided cancer surgery
Authors
P. A. Andersen
A. H. Chakera
T. L. Klausen
T. Binderup
H. S. Grossjohann
E. Friis
C. Palnaes Hansen
G. Schmidt
A. Kjaer
B. Hesse
Publication date
01-03-2008
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 3/2008
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-007-0532-0

Other articles of this Issue 3/2008

European Journal of Nuclear Medicine and Molecular Imaging 3/2008 Go to the issue